Letter from the CEO

When I joined Edwards Lifesciences eight years ago, I was drawn to the company’s focus on transforming the lives of patients with structural heart disease and the critically ill. Since my appointment to CEO, I have had the pleasure of connecting with many of our 17,000+ employees. I am proud of our strong globally-minded team and patient-focused culture.

One of the questions that came up during these recent employee interactions is, “What do we mean when we talk about ‘corporate sustainability’ at Edwards?” Sustainability reflects our unwavering commitment to innovating for patients with unmet needs and the impact we are having on society and our stakeholders. In short, I believe ensuring a sustainable future is core to everything we do at Edwards.

It is with this in mind that I am pleased to welcome you to Edwards Lifesciences’ 2022 Sustainability Report, which details the continued progress and commitment of Edwards to address the global needs of our stakeholders.

When Edwards became an independent company on April 3, 2000, we united around a Credo and a set of aspirations to define our culture and guide our actions. We closely align our sustainability focus areas, business goals and aspirations so that they work together to help us meet patient needs now and into the future.

Throughout 2022, the steadfast focus of our global teams has led to remarkable progress in bringing life-saving innovations to patients in need through our partnerships with clinicians, regulators, hospitals and health systems. Even during the challenges of the past several years, we remained committed to our patient-focused innovation strategy, continuing to invest in research and development and ensuring our resilient global supply chain met physician and patient needs. We have also continued to prioritize and grow our talented, dedicated and diverse employees. I’m honored to work alongside our experienced leadership team, united by a shared commitment to making a positive impact on patients, driving innovation and fostering growth.

By taking a long-term view and approach to our strategy and by maintaining our focus on the impact we have on key stakeholders, we are creating a sustainable company that will grow and thrive even in the face of unpredictable challenges.

We consider our impact on the environment in our projects, including the expansion of our headquarters in Irvine, Calif., and our manufacturing facilities around the world with six gold and two platinum LEED certifications. As noted in last year’s report, we have established a focus to achieve carbon neutrality by 2030 and 1.5°C science-based targets.

We appreciate your interest in the impact we have on society and look forward to fostering ongoing engagement with our stakeholders. By building trusted partnerships and acting with purpose, we aim to impact even more patients around the world.

Micheal Mussallem signature
Bernard J. Zovighian
Chief Executive Officer